评估集成电磁追踪在前列腺癌临床高剂量率近距离放疗中驻留位置监测的应用
本研究在20例接受双分次前列腺高剂量率近距离放疗单药治疗的患者中,评估电磁追踪(EMT)测量在经直肠超声(TRUS)和计算机断层扫描(CT)引导下的可靠性。TRUS引导下EMT与手动驻留位置(DP)确定的中位欧几里得距离(ED)为1.00 mm,参考传感器移动中位0.18 mm;CT引导下在CT室和治疗室测量的中位ED分别为1.60 mm和2.24 mm,参考传感器移动中位0.97 mm。结论认为EMT适用于TRUS引导下的质量保证和误差检测,在CT引导下能识别植入几何变化但准确性较低。
要点
- TRUS引导下EMT与手动DP确定的中位ED为1.00 mm,参考传感器移动中位0.18 mm。
- CT引导下CT室和治疗室测量的中位ED分别为1.60 mm和2.24 mm,参考传感器移动中位0.97 mm。
- 基于参考传感器的移动校正使CT引导治疗的ED显著但小幅降低。
核心结论
- EMT适用于TRUS引导的前列腺HDR-BT质量保证和误差检测;在CT引导下能识别植入几何随时间及患者重新定位后的变化,但准确性较低。
研究设计与样本
- 对20例接受双分次前列腺HDR-BT单药治疗的患者进行EMT测量,每分次生成个体化TRUS或CT治疗计划,并与手动重建针的DP比较,另在一根针内放置内部参考传感器评估内部移动水平及校正潜力。
主要发现
- TRUS引导治疗中,EMT测量与手动DP确定之间的中位ED为1.00 mm,参考传感器移动中位0.18 mm。
- CT引导治疗中,在CT室和治疗室测量的DP与CT-based DP确定相比,中位ED分别为1.60 mm和2.24 mm。
- CT引导治疗中观察到的参考传感器移动中位为0.97 mm。
- 实施基于参考传感器的移动校正使CT引导治疗的ED出现显著但小幅降低。
临床怎么用
- EMT可用于TRUS引导前列腺HDR-BT的质量保证和误差检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Electromagnetic Tracking (EMT) technology has been integrated in a prototype high-dose-rate brachytherapy (HDR-BT) afterloading device. Its potential for dwell position (DP) monitoring has earlier been demonstrated in prostate phantoms. However, its performance for prostate BT in the clinical setting remains to be assessed. AIM: Assess the reliability and value of EMT measurements in transrectal ultrasound-based (TRUS-based) and computed tomography-based (CT-based) prostate HDR-BT. METHODS: EMT measurements were conducted on 20 patients undergoing dual-fraction prostate HDR-BT monotherapy. In each treatment fraction an individual TRUS-based or CT-based treatment plan was generated. The measurements were compared to DPs of manually reconstructed needles in those TRUS-based or CT-based treatment plans. An internal reference sensor was also placed in one needle to assess internal movement levels and its potential for movement correction. RESULTS: For TRUS-based treatments, median Euclidean distances (ED) of 1.00 mm were observed between EMT measurements and manual DP determination. Reference sensor movement was minimal at a median of 0.18 mm. For DPs measured in the CT-room and treatment room, median EDs of 1.60 mm and 2.24 mm compared to CT-based DP determination respectively were observed, indicating the system's ability to detect changes in implant geometry over time and after patient repositioning. Median reference sensor movement of 0.97 mm was observed. Implementing reference sensor-based movement correction led to a significant but small decrease in ED for CT-based treatments. CONCLUSION: EMT is suitable for TRUS-based prostate HDR-BT quality assurance and error detection. While EMT can identify changes in implant geometry in CT-based prostate HDR-BT treatments, it showed lower accuracy in this setting.
引用
- Androulakis I, Schiphof-Godart J, van Heerden LE, et al. Assessment of integrated electromagnetic tracking for dwell position monitoring in a clinical HDR brachytherapy setting for prostate cancer. Radiother Oncol. 2024. PMID: 39191302. doi:10.1016/j.radonc.2024.110501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。